22 May 2013
Keywords: uk, gov, orders, 6m, doses, relenza, drug
Article | 09 February 2009
UK drug major GlaxoSmithKline has entered into a deal with the UK government to provide 10.6 million treatment courses of Relenza
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 February 2009
21 May 2013
© 2013 thepharmaletter.com